M. Bonomi, H. Abu-Sbeih, B. Klamer, M. Issa, F. Rind, K. Dibs, D. Konieczkowski, E. Gogineni, J. Pan, M. Old, E. Tili, A. Chakravarti, J. Grecula, S. Baliga, R. Carrau, J. Rocco, D. Blakaj, P. Bhateja
{"title":"每周使用紫杉醇、卡铂和西妥昔单抗 (PCC) 治疗使用免疫检查点抑制剂 (ICI) 后病情进展的复发性或转移性头颈部鳞状细胞癌 (RM-HNSCC):回顾性分析","authors":"M. Bonomi, H. Abu-Sbeih, B. Klamer, M. Issa, F. Rind, K. Dibs, D. Konieczkowski, E. Gogineni, J. Pan, M. Old, E. Tili, A. Chakravarti, J. Grecula, S. Baliga, R. Carrau, J. Rocco, D. Blakaj, P. Bhateja","doi":"10.1016/j.ijrobp.2024.01.094","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":14219,"journal":{"name":"International Journal of Radiation Oncology*Biology*Physics","volume":"48 15","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Weekly Paclitaxel, Carboplatin, and Cetuximab (PCC) as Treatment for Recurrent or Metastatic Head and Neck Squamous-cell Carcinoma (RM-HNSCC) that Progressed on Immune Checkpoint Inhibitors (ICI): A Retrospective Analysis\",\"authors\":\"M. Bonomi, H. Abu-Sbeih, B. Klamer, M. Issa, F. Rind, K. Dibs, D. Konieczkowski, E. Gogineni, J. Pan, M. Old, E. Tili, A. Chakravarti, J. Grecula, S. Baliga, R. Carrau, J. Rocco, D. Blakaj, P. Bhateja\",\"doi\":\"10.1016/j.ijrobp.2024.01.094\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":14219,\"journal\":{\"name\":\"International Journal of Radiation Oncology*Biology*Physics\",\"volume\":\"48 15\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Radiation Oncology*Biology*Physics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.ijrobp.2024.01.094\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Radiation Oncology*Biology*Physics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.ijrobp.2024.01.094","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Weekly Paclitaxel, Carboplatin, and Cetuximab (PCC) as Treatment for Recurrent or Metastatic Head and Neck Squamous-cell Carcinoma (RM-HNSCC) that Progressed on Immune Checkpoint Inhibitors (ICI): A Retrospective Analysis